{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T04:25:11Z","timestamp":1793939111035,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biomaterials.2022.121817","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T03:41:29Z","timestamp":1664336489000},"page":"121817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Modelling fatty liver disease with mouse liver-derived multicellular spheroids"],"prefix":"10.1016","volume":"290","author":[{"given":"Elise Anne","family":"van Os","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cools","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Eysackers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5852-2109","authenticated-orcid":false,"given":"Karolina","family":"Szafranska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla","family":"Smout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6566-6071","authenticated-orcid":false,"given":"Stefaan","family":"Verhulst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Reynaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-4590","authenticated-orcid":false,"given":"Peter","family":"McCourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Mannaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.","family":"van Grunsven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2022.121817_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.coph.2019.09.006","article-title":"New and emerging anti-fibrotic therapeutics entering or already in clinical trials in chronic liver diseases","volume":"49","author":"Lemoinne","year":"2019","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121817_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","article-title":"Pathobiology of liver fibrosis: a translational success story","volume":"64","author":"Lee","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.biomaterials.2022.121817_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154925","article-title":"Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease","volume":"126","author":"Negi","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.biomaterials.2022.121817_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154203","article-title":"Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis","volume":"111","author":"Polyzos","year":"2020","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","article-title":"Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats","volume":"142","author":"Xie","year":"2012","journal-title":"Gastroenterology"},{"issue":"46","key":"10.1016\/j.biomaterials.2022.121817_bib7","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.3748\/wjg.v12.i46.7413","article-title":"Role of Kupffer cells in the pathogenesis of liver disease","volume":"12","author":"Kolios","year":"2006","journal-title":"World J. Gastroenterol.: WJG"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121817_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.biomaterials.2022.121817_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2017.07.004","article-title":"3D in vitro models of liver fibrosis","volume":"121","author":"van Grunsven","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib10","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/jcm10010036","article-title":"In vitro and in vivo models of non-alcoholic fatty liver disease: a critical appraisal","volume":"10","author":"Soret","year":"2021","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","article-title":"Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies","volume":"50","author":"Popov","year":"2009","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121817_bib12","article-title":"Microengineered multi-organoid system from hiPSCs to recapitulate human liver-islet Axis in normal and type 2 diabetes","volume":"9","author":"Tao","year":"2022","journal-title":"Adv. Sci."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121817_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1089\/ten.tec.2018.0134","article-title":"Three-dimensional spheroid primary human hepatocytes in monoculture and coculture with nonparenchymal cells","volume":"24","author":"Baze","year":"2018","journal-title":"Tissue Eng. C Methods"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib14","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/hep.31772","article-title":"Hepatobiliary organoids and their applications for studies of liver health and disease: are we there yet?","volume":"74","author":"Shiota","year":"2021","journal-title":"Hepatology"},{"issue":"15","key":"10.1016\/j.biomaterials.2022.121817_bib15","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1177\/1535370216657448","article-title":"Cell sources for in vitro human liver cell culture models","volume":"241","author":"Zeilinger","year":"2016","journal-title":"Exp. Biol. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib16","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/cells9040964","article-title":"Human liver spheroids as a model to study aetiology and treatment of hepatic fibrosis","volume":"9","author":"Hurrell","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121817_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/ijms22031217","article-title":"Gene editing correction of a urea cycle defect in organoid stem cell derived hepatocyte-like cells","volume":"22","author":"Zabulica","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib18","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/abbdb2","article-title":"Development of a cost-effective automated platform to produce human liver spheroids for basic and applied research","volume":"13","author":"Lucendo-Villarin","year":"2020","journal-title":"Biofabrication"},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121817_bib19","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/cells11030442","article-title":"Current status and challenges of human induced pluripotent stem cell-derived liver models in drug discovery","volume":"11","author":"Tricot","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biomaterials.2022.121817_bib20","article-title":"Multiparametric material functionality of microtissue-based in vitro models as alternatives to animal testing","author":"Stengelin","year":"2022","journal-title":"Adv. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/laban.1217","article-title":"Improving quality of science through better animal welfare: the NC3Rs strategy","volume":"46","author":"Prescott","year":"2017","journal-title":"Lab. Anim."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121817_bib22","doi-asserted-by":"crossref","first-page":"G391","DOI":"10.1152\/ajpgi.00167.2007","article-title":"The liver sinusoidal endothelial cell: a cell type of controversial and confusing identity","volume":"294","author":"Elvevold","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121817_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/138920006778017759","article-title":"Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures","volume":"7","author":"Elaut","year":"2006","journal-title":"Curr. Drug Metabol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121817_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2022.121817_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biomaterials.2017.05.047","article-title":"Functionality based method for simultaneous isolation of rodent hepatic sinusoidal cells","volume":"139","author":"Stradiot","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121817_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120335","article-title":"The fibrotic response of primary liver spheroids recapitulates in vivo hepatic stellate cell activation","volume":"261","author":"Mannaerts","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121817_bib27","article-title":"A standardized method for the analysis of liver sinusoidal endothelial cells and their fenestrations by scanning electron microscopy","volume":"98","author":"Cogger","year":"2015","journal-title":"JoVE"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatology International"},{"key":"10.1016\/j.biomaterials.2022.121817_bib29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-\u03b2 signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12860-020-00331-9","article-title":"Transcriptome and proteome profiling reveal complementary scavenger and immune features of rat liver sinusoidal endothelial cells and liver macrophages","volume":"21","author":"Bhandari","year":"2020","journal-title":"BMC Molecular and Cell Biology"},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121817_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0030-1255353","article-title":"Toll-like receptor 4 and hepatic fibrogenesis","volume":"30","author":"Pradere","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121817_bib32","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ajpath.2017.01.021","article-title":"Toll-like receptor 4\u2013independent carbon tetrachloride\u2013induced fibrosis and lipopolysaccharide-induced acute liver injury in mice: role of hepatic stellate cells","volume":"187","author":"Kumar","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biomaterials.2022.121817_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2015.11.026","article-title":"Novel human hepatic organoid model enables testing of drug-induced liver fibrosis in vitro","volume":"78","author":"Leite","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2022.121817_bib34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.tox.2017.03.008","article-title":"Long-term acetaminophen treatment induced liver fibrosis in mice and the involvement of Egr-1","volume":"382","author":"Bai","year":"2017","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.plipres.2012.10.004","article-title":"Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease","volume":"52","author":"Leamy","year":"2013","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/10715760600943900","article-title":"Hydrogen peroxide and hydroxyl radicals mediate palmitate-induced cytotoxicity to hepatoma cells: relation to mitochondrial permeability transition","volume":"41","author":"Srivastava","year":"2007","journal-title":"Free Radic. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121817_bib37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhep.2007.09.009","article-title":"Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study","volume":"48","author":"Allard","year":"2008","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib38","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1038\/s41598-021-83974-8","article-title":"Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men","volume":"11","author":"van den Hoek","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121817_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/1751-2980.12967","article-title":"Efficacy and safety of drugs for nonalcoholic steatohepatitis","volume":"22","author":"Shen","year":"2021","journal-title":"J Dig Dis"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib40","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/s41598-017-09702-3","article-title":"Pioglitazone enhances cytosolic lipolysis, \u03b2-oxidation and autophagy to ameliorate hepatic steatosis","volume":"7","author":"Hsiao","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121817_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2020.02.027","article-title":"Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: results from randomized phase III STELLAR trials","volume":"73","author":"Harrison","year":"2020","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121817_bib42","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep4.1270","article-title":"Obeticholic acid modulates serum metabolites and gene signatures characteristic of human NASH and attenuates inflammation and fibrosis progression in Ldlr-\/-.Leiden mice","volume":"2","author":"Morrison","year":"2018","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121817_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/toxsci\/kfx289","article-title":"Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: a multicenter study","volume":"162","author":"Bell","year":"2018","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2020.04.025","article-title":"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages","volume":"73","author":"Lefere","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.biomaterials.2022.121817_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1475-2875-6-169","article-title":"Improved isolation of murine hepatocytes for in vitro malaria liver stage studies","volume":"6","author":"Gon\u00e7alves","year":"2007","journal-title":"Malar. J."},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121817_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235745","article-title":"Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity","volume":"15","author":"Nudischer","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib47","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.immuni.2019.08.017","article-title":"Stellate cells, hepatocytes, and endothelial cells imprint the kupffer cell identity on monocytes colonizing the liver macrophage niche","volume":"51","author":"Bonnardel","year":"2019","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121817_bib48","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41591-020-1102-2","article-title":"Acute liver failure is regulated by MYC- and microbiome-dependent programs","volume":"26","author":"Kolodziejczyk","year":"2020","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121817_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cell.2021.12.018","article-title":"Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches","volume":"185","author":"Guilliams","year":"2022","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF03188857","article-title":"Influence of rifampicin on the toxicity and the analgesic effect of acetaminophen","volume":"19","author":"Dimova","year":"1994","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"issue":"20","key":"10.1016\/j.biomaterials.2022.121817_bib51","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90954","article-title":"Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis","volume":"1","author":"Feaver","year":"2016","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121817_bib52","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \"hits","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121817_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3748\/wjg.v24.i2.179","article-title":"Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis","volume":"24","author":"T\u00f8lb\u00f8l","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121817_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/cts.12735","article-title":"A 3-week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death","volume":"13","author":"Briand","year":"2020","journal-title":"Clin Transl Sci"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121817_bib55","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hep4.1057","article-title":"The new-generation pan-peroxisome proliferator-activated receptor agonist IVA337 protects the liver from metabolic disorders and fibrosis","volume":"1","author":"Wettstein","year":"2017","journal-title":"Hepatol Commun"},{"issue":"18","key":"10.1016\/j.biomaterials.2022.121817_bib56","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2022.121817_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(16)01686-X","article-title":"Reduction of liver steatosis and fibrosis with an Ask1 inhibitor in a murine model of nash is accompanied by improvements in cholesterol, bile acid and lipid metabolism","volume":"64","author":"Budas","year":"2016","journal-title":"J. Hepatol."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:13:46Z","timestamp":1758906826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222004574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":57,"alternative-id":["S0142961222004574"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121817","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modelling fatty liver disease with mouse liver-derived multicellular spheroids","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"121817"}}